Clinical Trials Directory

Trials / Completed

CompletedNCT01969994

Absorption, Metabolism, and Excretion of (-)-[2-14C]Epicatechin in Humans

A Single-Center, Open-Label Study to Evaluate the Absorption, Metabolism, and Excretion of (-)-[2-14C]Epicatechin Following Oral Intake

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
The Institutes for Pharmaceutical Discovery, LLC · Industry
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the absorption, metabolism and excretion of (-)-epicatechin using the radiolabeled tracer (-)-\[2-14C\]epicatechin in healthy male volunteers observing a flavanol-/procyanidin-controlled background diet.

Detailed description

Flavanols and their oligomeric derivatives, the procyanidins, are plant-derived compounds commonly present in the human diet. Accumulating data demonstrate a causal role for dietary flavanols in mediating the cardiovascular benefits associated with the consumption of flavanol-/procyanidin-containing foods. In this context, there exists a great interest in understanding the absorption, distribution, metabolism and excretion (ADME) of flavanols in humans. While significant advances in understanding the ADME of flavanols were made, the data obtained thus far remain fairly preliminary and with significant shortfalls and seeming contradictions. Aimed at addressing the challenges and gaps of previous investigations, this study will investigate the ADME of (-)-epicatechin, one of the most abundant dietary flavanols, following the intake of radiolabeled (-)-\[2-14C\]epicatechin by healthy humans observing a flavanol-/procyanidin-controlled background diet.

Conditions

Interventions

TypeNameDescription
OTHERControlled dietary backgroundControlled dietary flavanol-/procyanidin- background, consisting of daily intake for 14 days (day -17 to -4) of a commercially available flavanol-/procyanidin-containing cocoa-based drink (250 mg cocoa flavanols; 40 mg of (-)-epicatechin) followed by a 4-day period (day -4 to 0) of a low-flavanol diet.
OTHER(-)-[2-14C]epicatechin intakeSingle oral intake of an aqueous solution of a mixture of non-radiolabeled (-)-epicatechin and a single-carbon-14 radiolabeled (-)-\[2-14C\]epicatechin. The target amount of EC delivered with test drink will be 60 mg, 58.5 mg of which consist of non-radiolabled EC and 1.54 mg (300 µCi) consist of (-)-\[2-14C\]epicatechin.

Timeline

Start date
2009-12-01
Primary completion
2009-12-01
Completion
2009-12-01
First posted
2013-10-25
Last updated
2013-10-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01969994. Inclusion in this directory is not an endorsement.